| Value | ₹162.2 Cr |
|---|
NSE filing, NSE: TREJHARA. Summary written from the filing by ALFA Finder's alert engine.
Trejhara Solutions Ltd: key numbers
- Share price
- ₹114.30
- Market cap
- ₹265.8 Cr
- Revenue (annual)
- ₹142.2 Cr
- Net profit (annual)
- ₹8.53 Cr
- P/E (TTM)
- 20.9×Sector 23.5×
- Promoter holding
- 33.87%+0.00% QoQ
- FII holding
- 0.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Trejhara Solutions Ltd
All →Trejhara Solutions Board Meeting Date
Trejhara Solutions scheduled its Board meeting for November 6, 2026 to consider Q3 FY27 results. The trading window is closed from October 1, 2026.
Trejhara Solutions Other Announcement
Trejhara Solutions Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Trejhara Solutions Annual General Meeting
Trejhara Solutions Limited held its 9th Annual General Meeting on September 21, 2026, transacting ordinary and special business as per the notice of the AGM.
Trejhara Solutions Other Announcement
Trejhara Solutions Limited has shared a letter with shareholders providing website links to access the Annual Report and Notice of the 9th Annual General Meeting.
Trejhara Solutions Annual General Meeting
Trejhara Solutions Limited has announced its 09th Annual General Meeting to be held on September 21, 2026. The meeting will be conducted via video conferencing.
Trejhara Solutions Annual Report
Trejhara Solutions has submitted its Annual Report for the financial year 2025-26. The company's 9th Annual General Meeting is scheduled for September 21, 2026.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.